Cargando…

Is There a Link between Bisphenol A (BPA), a Key Endocrine Disruptor, and the Risk for SARS-CoV-2 Infection and Severe COVID-19?

Infection by the severe acute respiratory syndrome (SARS) coronavirus-2 (SARS-CoV-2) is the causative agent of a new disease (COVID-19). The risk of severe COVID-19 is increased by certain underlying comorbidities, including asthma, cancer, cardiovascular disease, hypertension, diabetes, and obesity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zahra, Aeman, Sisu, Cristina, Silva, Elisabete, De Aguiar Greca, Sophie-Christine, Randeva, Harpal S., Chatha, Kamaljit, Kyrou, Ioannis, Karteris, Emmanouil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602132/ https://www.ncbi.nlm.nih.gov/pubmed/33066495 http://dx.doi.org/10.3390/jcm9103296

Ejemplares similares

Involvement of the Endocrine-Disrupting Chemical Bisphenol A (BPA) in Human Placentation
por: de Aguiar Greca, Sophie-Christine, et al.
Publicado: (2020)

Impact of Environmentally Relevant Concentrations of Bisphenol A (BPA) on the Gene Expression Profile in an In Vitro Model of the Normal Human Ovary
por: Zahra, Aeman, et al.
Publicado: (2022)

Identification of Potential Bisphenol A (BPA) Exposure Biomarkers in Ovarian Cancer
por: Zahra, Aeman, et al.
Publicado: (2021)

Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic
por: Kyrou, Ioannis, et al.
Publicado: (2020)

Neuropilin-1 as a new potential SARS-CoV-2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID-19
por: Davies, Julie, et al.
Publicado: (2020)

Co-expression of peripheral olfactory receptors with SARS-CoV-2 infection mediators: Potential implications beyond loss of smell as a COVID-19 symptom
por: Kerslake, Rachel, et al.
Publicado: (2020)

Pan-cancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARS-CoV-2 infection leading to COVID-19
por: Katopodis, Periklis, et al.
Publicado: (2020)

In Silico Study to Predict the Structural and Functional Consequences of SNPs on Biomarkers of Ovarian Cancer (OC) and BPA Exposure-Associated OC
por: Zahra, Aeman, et al.
Publicado: (2022)

Not only ACE2—the quest for additional host cell mediators of SARS-CoV-2 infection: Neuropilin-1 (NRP1) as a novel SARS-CoV-2 host cell entry mediator implicated in COVID-19
por: Kyrou, Ioannis, et al.
Publicado: (2021)

Differential Regulation of Genes by the Glucogenic Hormone Asprosin in Ovarian Cancer
por: Kerslake, Rachel, et al.
Publicado: (2022)

Transcriptional Landscape of 3D vs. 2D Ovarian Cancer Cell Models
por: Kerslake, Rachel, et al.
Publicado: (2023)

Differential Expression of RAD51AP1 in Ovarian Cancer: Effects of siRNA In Vitro
por: Filipe, Alice, et al.
Publicado: (2022)

COVID-19 and SARS-CoV-2 host cell entry mediators: Expression profiling of TMRSS4 in health and disease
por: Katopodis, Periklis, et al.
Publicado: (2021)

Cardiovascular Biomarkers: Lessons of the Past and Prospects for the Future
por: Omran, Farah, et al.
Publicado: (2022)

Endocrine Disruptors: Bisphenol A and the Brain
por: Barrett, Julia R.
Publicado: (2006)

Endocrine Disruptor Bisphenol A (BPA) Triggers Systemic Para-Inflammation and is Sufficient to Induce Airway Allergic Sensitization in Mice
por: Loffredo, Lucas Fedele, et al.
Publicado: (2020)

Host cell entry mediators implicated in the cellular tropism of SARS-CoV-2, the pathophysiology of COVID-19 and the identification of microRNAs that can modulate the expression of these mediators (Review)
por: Katopodis, Periklis, et al.
Publicado: (2022)

The Molecular Mechanism of Bisphenol A (BPA) as an Endocrine Disruptor by Interacting with Nuclear Receptors: Insights from Molecular Dynamics (MD) Simulations
por: Li, Lanlan, et al.
Publicado: (2015)

BPA Endocrine Disruptor Detection at the Cutting Edge: FPIA and ELISA Immunoassays
por: Raysyan, Anna, et al.
Publicado: (2023)

Involvement of the glutamine RF-amide peptide and its cognate receptor GPR103 in prostate cancer
por: Kawan, Mohamed Ab., et al.
Publicado: (2019)

A pancancer overview of FBN1, asprosin and its cognate receptor OR4M1 with detailed expression profiling in ovarian cancer
por: Kerslake, Rachel, et al.
Publicado: (2021)

The Endocrine Disruptor Compound Bisphenol-A (BPA) Regulates the Intra-Tumoral Immune Microenvironment and Increases Lung Metastasis in an Experimental Model of Breast Cancer
por: Palacios-Arreola, Margarita Isabel, et al.
Publicado: (2022)

Elevated Circulating Lactate Levels and Widespread Expression of Its Cognate Receptor, Hydroxycarboxylic Acid Receptor 1 (HCAR1), in Ovarian Cancer
por: Kerslake, Rachel, et al.
Publicado: (2022)

The Endocrine Disruptor Bisphenol A (BPA) Affects the Enteric Neurons Immunoreactive to Neuregulin 1 (NRG1) in the Enteric Nervous System of the Porcine Large Intestine
por: Szymańska, Kamila, et al.
Publicado: (2020)

Occurrence and Profiles of the Artificial Endocrine Disruptor Bisphenol A and Natural Endocrine Disruptor Phytoestrogens in Urine from Children in China
por: Zhang, Mingyue, et al.
Publicado: (2015)

The Role of Cholesterol in the Interaction of the Lipid Monolayer with the Endocrine Disruptor Bisphenol-A
por: Katata, Victoria M., et al.
Publicado: (2022)

Asprosin Exerts Pro-Inflammatory Effects in THP-1 Macrophages Mediated via the Toll-like Receptor 4 (TLR4) Pathway
por: Shabir, Kiran, et al.
Publicado: (2022)

NUCB2/Nesfatin-1 Reduces Obesogenic Diet Induced Inflammation in Mice Subcutaneous White Adipose Tissue
por: Gharanei, Seley, et al.
Publicado: (2022)

Exposure to Endocrine Disruptors (Di(2-Ethylhexyl)phthalate (DEHP) and Bisphenol A (BPA)) in Women from Different Residing Areas in Italy: Data from the LIFE PERSUADED Project
por: Carli, Fabrizia, et al.
Publicado: (2022)

Bisphenol A (BPA) the mighty and the mutagenic
por: Jalal, Nasir, et al.
Publicado: (2017)

Effects of Bisphenol-A and Other Endocrine Disruptors Compared With Abnormalities of Schizophrenia: An Endocrine-Disruption Theory of Schizophrenia
por: Brown, James S.
Publicado: (2009)

COVID-19 and diabetes: No time to drag our feet during an untimely pandemic()
por: Kyrou, Ioannis, et al.
Publicado: (2020)

Atherosclerotic and Cardio-Metabolic Diseases: From Molecular Basis to Therapeutic Advances
por: Kassi, Eva, et al.
Publicado: (2023)

Protein expression of transmembrane protease serine 4 in the gastrointestinal tract and in healthy, cancer, and SARS-CoV-2 infected lungs
por: Kerslake, Rachel, et al.
Publicado: (2022)

Polycystic Ovary Syndrome and Endocrine Disruptors (Bisphenols, Parabens, and Triclosan)—A Systematic Review
por: Srnovršnik, Tinkara, et al.
Publicado: (2023)

Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE((-/-)) Mice by Activating Autophagy and Reducing ER Stress and Apoptosis
por: Nasiri-Ansari, Narjes, et al.
Publicado: (2021)

Relationship between endocrine disruptors and obesity with a focus on bisphenol A: a narrative review
por: Boudalia, Sofiane, et al.
Publicado: (2021)

Vitamin D ameliorates liver pathology in mice caused by exposure to endocrine disruptor bisphenol A
por: Al-Griw, Mohamed A., et al.
Publicado: (2023)

Endocrine disruptors also function as nervous disruptors and can be renamed endocrine and nervous disruptors (ENDs)
por: Seralini, Gilles-Eric, et al.
Publicado: (2021)

Plastics Derived Endocrine Disruptors (BPA, DEHP and DBP) Induce Epigenetic Transgenerational Inheritance of Obesity, Reproductive Disease and Sperm Epimutations
por: Manikkam, Mohan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_flvrurpff77mslecngc2upesig